Christopher Yeung, MD
Orthopedic Surgery · Phoenix, AZNPI 1205864006
Payments from drug & device makers
What this record shows
The money is spread across several categories — royalties or licence payments (52.3%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 39 manufacturers reported payments, led by Stryker at 48.0% of the total. Reporting peaked in 2019 at $1,452,740 and has fallen 83.9% since, to $233,635 in 2025.
Across 606 payments — averaging $4406.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$1.3M
- Globus Medical$907K
- Arthrex$375K
- Spineology Inc.$57K
- Medical Device Business Services, Inc.$15K
- Medacta USA, Inc.$15K
- plus $19K from 33 others
Across 57 payments — averaging $5278.12 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Orthofix Medical, Inc.$293K
- Relievant Medsystems, Inc.$8K
Across 5 payments — averaging $36,141 each. An ownership or investment interest held by the physician or an immediate family member.
- Amplify Surgical, Inc.$181K
What the payments were for
- Royalty or licence$1,395,84452%
- Consulting fees$101,1044%
- Speaking & faculty fees$1,102,42241%
- Travel & lodging$55,1632%
- Food & beverage$15,5531%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RISE$896,360
- ES2$458,640
- OPTIMESH EXPANDABLE INTERBODY FUSION SYSTEM$47,760
- VIPER$22,405
- CONCORDE$15,150
- MYSPINE$15,021
- COUGAR$13,163
- ViviGen$13,163
- CORBEL$8,189
- DUO TI EXPANDABLE INTERBODY FUSION SYSTEM$8,180
- ARTHREX$7,018
- CALIBER$1,499
- MAKO$1,070
- NANOSS ABGS FAMILY$819
- Other - Miscellaneous$684
- SPINE INSTRUMENTS ENDOSCOPIC INSTRUMENT SETS$357
- aprevo$252
- RISE Intra LIF$190
- CASCADIA INTERBODY SYSTEM$164
- Sagittae$145
How this compares
Too few orthopedic surgery providers in Arizonato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 12 | $384 |
| Gabapentin | 15 | $165 |
| Meloxicam | 21 | $140 |
| Methylprednisolone | 16 | $113 |
| Naproxen | 11 | $22 |
Paid to pharmacies, not to this prescriber.
Other orthopedic surgery in Phoenix
- Michael LeePhoenix$6K
- Michael WengPhoenix$2K
- Sepein ChiangPhoenix$0
- Leonard BodellPhoenix$0
- Sherif DabashTucson$11K
- Gregory PeareYuma$4K
- Christopher HamiltonScottsdale$4K
- Randall HardisonChandler$1K
- Andre MatthewsMesa$180
- Janet WhirlowScottsdale$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.